Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 7157169, 7 pages
http://dx.doi.org/10.1155/2016/7157169
Research Article

Laboratory Indicators of Aggrecan Turnover in Juvenile Idiopathic Arthritis

Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Silesia, Ulica Jedności 8, 41-200 Sosnowiec, Poland

Received 13 October 2015; Revised 29 December 2015; Accepted 10 January 2016

Academic Editor: Fabrizia Bamonti

Copyright © 2016 Katarzyna Winsz-Szczotka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. S. Fox, A. Bedi, and S. A. Rodeo, “The basic science of human knee menisci: structure, composition, and function,” Sports Health, vol. 4, no. 4, pp. 340–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. E. Wilusz, J. Sanchez-Adams, and F. Guilak, “The structure and function of the pericellular matrix of articular cartilage,” Matrix Biology, vol. 39, pp. 25–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Mort and C. J. Billington, “Articular cartilage and changes in arthritis: matrix degradation,” Arthritis Research, vol. 3, no. 6, pp. 337–341, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Hayes, D. Tudor, M. A. Nowell, B. Caterson, and C. E. Hughes, “Chondroitin sulfate sulfation motifs as putative biomarkers for isolation of articular cartilage progenitor cells,” Journal of Histochemistry and Cytochemistry, vol. 56, no. 2, pp. 125–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Martel-Pelletier, S. Kwan Tat, and J.-P. Pelletier, “Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review,” Osteoarthritis and Cartilage, vol. 18, supplement 1, pp. S7–S11, 2010. View at Publisher · View at Google Scholar
  6. C. Kiani, L. Chen, Y. J. Wu, A. J. Yee, and B. B. Yang, “Structure and function of aggrecan,” Cell Research, vol. 12, no. 1, pp. 19–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Winsz-Szczotka, K. Komosińska-Vassev, K. Kuźnik-Trocha, A. Gruenpeter, I. Lachór-Motyka, and K. Olczyk, “Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis,” Clinical Biochemistry, vol. 47, no. 9, pp. 829–834, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Martel-Pelletier, C. Boileau, J.-P. Pelletier, and P. J. Roughley, “Cartilage in normal and osteoarthritis conditions,” Best Practice and Research: Clinical Rheumatology, vol. 22, no. 2, pp. 351–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Winsz-Szczotka, K. Komosińska-Vassev, K. Kuźnik-Trocha, A. Siwiec, B. Zegleń, and K. Olczyk, “Circulating keratan sulfate as a marker of metabolic changes of cartilage proteoglycan in juvenile idiopathic arthritis; influence of growth factors as well as proteolytic and prooxidative agents on aggrecan alterations,” Clinical Chemistry and Laboratory Medicine, vol. 53, no. 2, pp. 291–297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Lipińska, S. Lipińska, J. Stańczyk et al., “Reactive oxygen species and serum antioxidant defense in juvenile idiopathic arthritis,” Clinical Rheumatology, vol. 34, no. 3, pp. 451–456, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. J. Parsons, “Oxidation of glycosaminoglycans by free radicals and reactive oxidative species: a review of investigative methods,” Free Radical Research, vol. 49, no. 5, pp. 618–632, 2015. View at Publisher · View at Google Scholar
  12. G. M. Campo, A. Avenoso, S. Campo et al., “Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures,” Cell Biology International, vol. 30, no. 1, pp. 21–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Egea, A. G. García, J. Verges, E. Montell, and M. G. López, “Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans,” Osteoarthritis and Cartilage, vol. 18, no. 1, pp. S24–S27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Volpi, M. Cusmano, and T. Venturelli, “Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1243, no. 1, pp. 49–58, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Olczyk, A. Głowacki, and E. M. Koźma, “Non-insulin-dependent diabetes mellitus-associated changes in serum glycosaminoglycans,” Pathophysiology, vol. 4, no. 2, pp. 121–129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Blumenkrantz and G. Asboe-Hansen, “New method for quantitative determination of uronic acids,” Analytical Biochemistry, vol. 54, no. 2, pp. 484–489, 1973. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Aebi, “Catalase,” in Methods of Enzymatic Analysis, W. U. Bergmayer, Ed., pp. 673–684, Academic Press, New York, NY, USA, 1974. View at Google Scholar
  18. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. M. Campo, A. Avenoso, S. Campo et al., “Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes,” Innate Immunity, vol. 14, no. 4, pp. 233–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Kobayashi, M. Nishikawa, K. Hyoudou, F. Yamashita, and M. Hashida, “Hydrogen peroxide-mediated nuclear factor κB activation in both liver and tumor cells during initial stages of hepatic metastasis,” Cancer Science, vol. 99, no. 8, pp. 1546–1552, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. R. E. Simmonds and B. M. Foxwell, “Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation,” Rheumatology, vol. 47, no. 5, pp. 584–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. N. W. D. Jansen, G. Roosendaal, B. Lundin et al., “The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy,” Arthritis and Rheumatism, vol. 60, no. 1, pp. 290–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Rizkalla, A. Reiner, E. Bogoch, and A. R. Poole, “Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: evidence for molecular heterogeneity and extensive molecular changes in disease,” Journal of Clinical Investigation, vol. 90, no. 6, pp. 2268–2277, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Conrozier, J.-C. Balblanc, P. Richette et al., “Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study,” Journal of Orthopaedic Research, vol. 30, no. 5, pp. 679–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Komosinska-Vassev, P. Olczyk, K. Winsz-Szczotka, K. Klimek, and K. Olczyk, “Plasma biomarkers of oxidative and AGE-mediated damage of proteins and glycosaminoglycans during healthy ageing: a possible association with ECM metabolism,” Mechanisms of Ageing and Development, vol. 133, no. 8, pp. 538–548, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. P.-J. Wipff, D. B. Rifkin, J.-J. Meister, and B. Hinz, “Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix,” Journal of Cell Biology, vol. 179, no. 6, pp. 1311–1323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Horiguchi, M. Ota, and D. B. Rifkin, “Matrix control of transforming growth factor-β function,” The Journal of Biochemistry, vol. 152, no. 4, pp. 321–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kamphuis, K. Hrafnkelsdóttir, M. R. Klein et al., “Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health,” Arthritis Research and Therapy, vol. 8, article R178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. B. György, L. Tóthfalusi, G. Nagy et al., “Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritis,” Arthritis Research and Therapy, vol. 10, article R110, 2008. View at Publisher · View at Google Scholar · View at Scopus